Journal of Osteoporosis [15] H.-J. Wang and P. A. Murphy, “isoﬂavone composition of American and Japanese soybeans in Iowa: eﬀects of variety, crop year, and location,” Journal of Agricultural and Food Chemistry, vol. 42, no. 8, pp. 1674–1677, 1994. [16] T. Cornwell, W. Cohick, and I. Raskin, “Dietary phytoestro- gens and health,” Phytochemistry, vol. 65, no. 8, pp. 995–1016, 2004. [17] M. J. de Kleijn, Y. T. Van der Schouw, P. W. F. Wilson, et al., “Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the framingham study,” Journal of Nutrition, vol. 131, no. 6, pp. 1826–1832, 2001. [18] H. Adlercreutz, H. Markkanen, and S. Watanabe, “Plasma concentrations of phyto-oestrogens in Japanese men,” The Lancet, vol. 342, no. 8881, pp. 1209–1210, 1993. [19] S. Zhou, G. Turgeman, S. E. Harris, et al., “Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells,” Molecular Endocrinology, vol. 17, no. 1, pp. 56–66, 2003. [20] S. Nilsson and J.-A. Gustafsson, “Biological role of estrogen and estrogen receptors,” Critical Reviews in Biochemistry and Molecular Biology, vol. 37, no. 1, pp. 1–28, 2002. [21] M. Yamaguchi, “isoﬂavone and bone metabolism: its cellular mechanism and preventive role in bone loss,” Journal of Health Science, vol. 48, no. 3, pp. 209–222, 2002. [22] A. Brzezinski and A. Debi, “Phytoestrogens: the “natural” selective estrogen receptor modulators?” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 85, no. 1, pp. 47–51, 1999. [23] J. M. Riddle and J. W. Estes, “Oral contraceptives in ancient and medieval times,” American Scientist, vol. 80, pp. 226–233, 1992. [24] R. J. Miksicek, “Commonly occurring plant ﬂavonoids have estrogenic activity,” Molecular Pharmacology, vol. 44, no. 1, pp. 37–43, 1993. [25] G. G. J. M. Kuiper, J. G. Lemmen, B. Carlsson, et al., “Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β,” Endocrinology, vol. 139, no. 10, pp. 4252– 4263, 1998. [26] D. Wang, J. Gutkowska, M. Marcinkiewicz, G. Rachelska, and M. Jankowski, “Genistein supplementation stimulates the oxytocin system in the aorta of ovariectomized rats,” Cardiovascular Research, vol. 57, no. 1, pp. 186–194, 2003. [27] S. C. Ho, S. G. Chan, Q. Yi, E. Wong, and P. C. Leung, “Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women,” Journal of Bone and Mineral Research, vol. 16, no. 7, pp. 1363–1369, 2001. [28] K. E. Wangen, A. M. Duncan, B. E. Merz-Demlow, et al., “Eﬀects of soy isoﬂavones on markers of bone turnover in premenopausal and postmenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3043–3048, 2000. [29] N. Omi, S. Aoi, K. Murata, and I. Ezawa, “Evaluation of the eﬀect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporo- sis.,” Journal of Nutritional Science and Vitaminology, vol. 40, no. 2, pp. 201–211, 1994. [30] B. H. Arjmandi, R. Birnbaum, N. V. Goyal, et al., “Bone- sparing eﬀect of soy protein in ovarian hormone-deﬁcient rats is related to its isoﬂavone content,” American Journal of Clinical Nutrition, vol. 68, no. 6, pp. 1364S–1368S, 1998. [31] B. H. Arjmandi, M. J. Getlinger, N. V. Goyal, et al., “The role of soy protein with normal or reduced isoﬂavone content in 7 reversing bone loss induced by ovarian hormone deﬁciency in rats,” American Journal of Clinical Nutrition, vol. 68, no. 6, supplement, pp. 1358S–1363S, 1998. [32] C. Picherit, B. Chanteranne, C. Bennetau-Pelissero, et al., “Dose-dependent bone-sparing eﬀects of dietary isoﬂavones in the ovariectomised rat,” British Journal of Nutrition, vol. 85, no. 3, pp. 307–316, 2001. [33] C. Picherit, C. Bennetau-Pelissero, B. Chanteranne, et al., “Soybean isoﬂavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariec- tomized rats,” Journal of Nutrition, vol. 131, no. 3, pp. 723–728, 2001. [34] J. J. B. Anderson, W. W. Ambrose, and S. C. Garner, “Biphasic eﬀects of genistein on bone tissue in the ovariectomized, lactating rat model,” Proceedings of the Society for Experimental Biology and Medicine, vol. 217, no. 3, pp. 345–350, 1998. [35] P. Fanti, M. C. Monier-Faugere, Z. Geng, et al., “The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats,” Osteoporosis International, vol. 8, no. 3, pp. 274–281, 1998. [36] C. Picherit, V. Coxam, C. Bennetau-Pelissero, et al., “Daidzein is more eﬃcient than genistein in preventing ovariectomy- induced bone loss in rats,” Journal of Nutrition, vol. 130, no. 7, pp. 1675–1681, 2000. [37] G. A. Greendale, G. FitzGerald, M.-H. Huang, et al., “Dietary soy isoﬂavones and bone mineral density: results from the Study of Women’s Health Across the Nation,” American Journal of Epidemiology, vol. 155, no. 8, pp. 746–754, 2002. [38] D. L. Alekel, A. S. Germain, C. T. Peterson, K. B. Hanson, J. W. Stewart, and T. Toda, “isoﬂavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women,” American Journal of Clinical Nutrition, vol. 72, no. 3, pp. 844–852, 2000. [39] N. Morabito, A. Crisafulli, C. Vergara, et al., “Eﬀects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double- blind placebo-controlled study,” Journal of Bone and Mineral Research, vol. 17, no. 10, pp. 1904–1912, 2002. [40] S. M. Potter, J. A. Baum, H. Teng, R. J. Stillman, N. F. Shay, and J. W. Erdman Jr., “Soy protein and isoﬂavones: their eﬀects on blood lipids and bone density in postmenopausal women,” American Journal of Clinical Nutrition, vol. 68, no. 6, supplement, pp. 1375S–1379S, 1998. [41] J. Mei, S. S. C. Yeung, and A. W. C. Kung, “High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 11, pp. 5217–5221, 2001. [42] E. Brink, V. Coxam, S. Robins, K. Wahala, A. Cassidy, and F. Branca, “Long-term consumption of isoﬂavone-enriched foods does not aﬀect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a ran- domized, double-blind, placebo controlled study,” American Journal of Clinical Nutrition, vol. 87, no. 3, pp. 761–770, 2008. [43] J. Liu, S. C. Ho, Y.-X. Su, W.-Q. Chen, C.-X. Zhang, and Y.- M. Chen, “Eﬀect of long-term intervention of soy isoﬂavones on bone mineral density in women: a meta-analysis of randomized controlled trials,” Bone, vol. 44, no. 5, pp. 948– 953, 2009. [44] T. Horiuchi, T. Onouchi, M. Takahashi, H. Ito, and H. Orimo, “Eﬀect of soy protein on bone metabolism in postmenopausal Japanese women,” Osteoporosis International, vol. 11, no. 8, pp. 721–724, 2000.